Browse > Article
http://dx.doi.org/10.5392/JKCA.2013.13.08.308

Comparison of ASCUS and Human Papilloma Virus  

Park, Mi-Soon (한서대학교 보건의료학과)
Chang, Byoung-Soo (한서대학교 피부미용학과)
Publication Information
Abstract
Among 179 specimen diagnosed with ASCUS but did not go through biopsy or other tests, 26 cases (14.52%) showed positivity in HPV Hybrid Capture II Test. There were 25 cases of HPV high risk factor(+), marking 13.96%, and 3 cases of low risk factor(+) at 1.67%. According to cytology manifestation, patients with over LSIL can increase their complete recovery rate with continuous tests, but most patients diagnosed ASCUS do not go through any tests at all. It is considered that in order to prevent and start early treatment on cervical cancer, the HPV Hybrid Capture II Test must be enforced to patients diagnosed with ASCUS. Negative patients should go through routine screening, and positive patients should receive treatment after colposcopy.
Keywords
ASCUS; HC II Test; HPV; Pap Smear;
Citations & Related Records
연도 인용수 순위
  • Reference
1 M. L. Williams, D. L. Rimm, M. A. Pedigo, and W. J. Frable, "Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from a academic medical center," Diagn Cytopathol, Vol.16, pp.1-7, 1997.   DOI
2 K. W. Alanen, L. M. Elit, P. A. Molinaro, and C. M. McLachlin, "Accesment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesion," Cancer, Vol.84, pp.5-10, 1988.
3 K. A. Dvorak, M. Finnemore, and J. A. Mksem, "Histology correlation with atypical squamous cells of undetermined significance(ASCUS) or low grade squamous intraepithelial lesion(LSIL) cytology diagnosis: an argument to ensure ASCUS follow-up that is as aggressive as that for LSIL," Diagn Cytopathol, Vol.21, pp.292-295, 1999.   DOI   ScienceOn
4 I. Nindil, A. Lorincz, I. Mielzynska, U. Petry, S. Baur, R. Kirchmayr, W. Michels, and A. Schneider, "Human papilloma virus detection in cervical intraneoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods," Clin Diagn Virol, Vol.10, pp.49-56, 1998.   DOI   ScienceOn
5 T. C. Wright, X. W. Sun, and J. Koulos, "Comparision of management algorythms for the evaluation of women with low-grade cytologic abnormalities," Obstet Gynecol, Vol.85, pp.202-210, 1995.   DOI   ScienceOn
6 C. Perrons, R. Jelley, B. Klete, W. Quint, and N. Brink, "Detection of persistent high risk human papilloma virus injections with hybrid capture II and SPF10/LiPA, J Clin Virol, Vol.32, pp.278-285, 2005.   DOI   ScienceOn
7 World Health Organization, "WHO position on HPV vaccines," Vaccine, Vol.27, pp.7236-7237, 2009.   DOI   ScienceOn
8 N. Munoz, F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. Shah, and P. J. Snijders, "Epidermiologic classification of human papillomavirus types associated with cervical cancer," N Engl J Med, Vol.348, pp.518-527, 2003.   DOI   ScienceOn
9 A. Schneider, "Cervical and vaginal HPV infections," Clin Dermatol, Vol.15, pp.389-398, 1997.   DOI   ScienceOn
10 C. S. Herrington, M. F. Evans, W. Gray, and J. O. D. McGee, "Morphological correlation of human papilloma virus infection of matched cervical smears and bioscopes from patients with persistant mild cervical cytological abnorminalities," Human Pathol, Vol.26, pp.951-955, 1995.   DOI   ScienceOn
11 L. C. R. Tewari, and C. A. Chaudhary, "Atypical squamous cells of undetermined significance, a follow up study," MJAFI, Vol.66, pp.225-227, 2010.
12 R. Kurman, and D. Solomon, "The bethesda system for reporting cervical/vaginal cytologic diagnosis: definitions, criteria and explanatory notes for terminology and specimen adequacy," New York, Springer Verlag, pp.148-156, 1994.
13 F. X. Bosch, M. M. Manos, and N. Munoz, "Prevalence of human papilloma virus in cervical cancer: a worldwide perspective," J Natl Cancer Inst, Vol.87, pp.796-802, 1995.   DOI   ScienceOn
14 M. del Pino, L. Rodriguez-Carunchio, I. Alonso, A. Torne, A. Rodriguez, P. Fuste, P. Castillo, N. Nonell, N. Abu-Lhiga, and J. Ordi, "Clinical, colposcopic and pathological charateristics of cervical and vaginal high-grade negative for HPV by Hybrid Capture 2," Gynecol Oncol, Vol.122, pp.515-520, 2011.   DOI   ScienceOn